When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DXCM - Dexcom: Positive Catalysts Ahead To Support Growth
DexCom Inc.
2024-05-13 13:30:15 ET
Summary
Dexcom is a buy despite a recent slowdown in US sales. The upcoming launch of Stelo, a glucose monitor for non-insulin users, has a large potential market and is expected.
Ex-US growth remains strong at 26%, and conservative management guidance suggests confidence in future performance. Historically, Dexcom has exceeded revenue guidance.
Lower than expected adoption of Stelo and challenges in the Japan sales model transition are potential risks.